Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Routy

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Gut Microbes|July 15, 2026
Dietary intervention through bacterial-derived butyrate elicits anti-tumor activity and increases anti-PD-1 responseMyriam Benlaïfaoui, Corentin Richard, Sébastien Hunter, et al.
Microbiome|May 5, 2026
Metagenomics and culturomics reveal the dual role of the gut microbiome in the development of immune-related toxicities and the efficacy of immune checkpoint inhibitors in cancerKhoudia Diop, Myriam Benlaïfaoui, Sébastien Hunter, et al.
Nature Communications|September 15, 2024
The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteersMeriem Messaoudene, Stéphanie Ferreira, Nathalie Saint-Lu, et al.
JTO Clinical and Research Reports|December 3, 2024
CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLCAntoine Desilets, Gabryella Pinheiro, Wiam Belkaid, et al.
Oncoimmunology|September 16, 2020
Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitorsRomain Daillère, Bertrand Routy, Anne-Gaëlle Goubet, et al.
Open Forum Infectious Diseases|September 23, 2020
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut MicrobiotaStéphane Isnard, John Lin, Brandon Fombuena, et al.
Nature Communications|November 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancerAnaïs Perrichet, Julie Lecuelle, Emeric Limagne, et al.
Frontiers in Oncology|August 7, 2023
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort studyMarion Tonneau, Kim Phan, Venkata S K Manem, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2020
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort studyArielle Elkrief, Antoine Desilets, Neha Papneja, et al.
Oral Oncology|November 25, 2023
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinomaCecilia Hes, Antoine Desilets, Marion Tonneau, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Gut Microbes|July 15, 2026
Dietary intervention through bacterial-derived butyrate elicits anti-tumor activity and increases anti-PD-1 responseMyriam Benlaïfaoui, Corentin Richard, Sébastien Hunter, et al.
Microbiome|May 5, 2026
Metagenomics and culturomics reveal the dual role of the gut microbiome in the development of immune-related toxicities and the efficacy of immune checkpoint inhibitors in cancerKhoudia Diop, Myriam Benlaïfaoui, Sébastien Hunter, et al.
Nature Communications|September 15, 2024
The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteersMeriem Messaoudene, Stéphanie Ferreira, Nathalie Saint-Lu, et al.
JTO Clinical and Research Reports|December 3, 2024
CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLCAntoine Desilets, Gabryella Pinheiro, Wiam Belkaid, et al.
Oncoimmunology|September 16, 2020
Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitorsRomain Daillère, Bertrand Routy, Anne-Gaëlle Goubet, et al.
Open Forum Infectious Diseases|September 23, 2020
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut MicrobiotaStéphane Isnard, John Lin, Brandon Fombuena, et al.
Nature Communications|November 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancerAnaïs Perrichet, Julie Lecuelle, Emeric Limagne, et al.
Frontiers in Oncology|August 7, 2023
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort studyMarion Tonneau, Kim Phan, Venkata S K Manem, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2020
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort studyArielle Elkrief, Antoine Desilets, Neha Papneja, et al.
Oral Oncology|November 25, 2023
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinomaCecilia Hes, Antoine Desilets, Marion Tonneau, et al.
Pageof 13